It’s been just over a month since our Patient-Focused Drug Development (PFDD) meeting on hyperhidrosis (Hh), but the process is not over. Your – and our -- input will help shape the future of hyperhidrosis care. PFDDs are an important way for us to make our voices and needs heard by treatment developers, healthcare providers, and the U.S. Food and Drug Administration (FDA). Have your say and comment via a “PFDD Comment” email.
This is a watershed moment for hyperhidrosis. The International Hyperhidrosis Society hosted a Patient-Focused Drug Development meeting in Washington, DC on November 13, 2017 designed to ensure that those affected by hyperhidrosis can make their voices – and needs -- heard by treatment developers, healthcare providers, and regulatory professionals from the U.S. Food and Drug Administration (FDA). If you’ve ever wanted a better way to control your sweating – and to stop sweating from controlling your life – it’s time to speak up - OPEN COMMENT PERIOD NEEDS YOUR INPUT NOW.
A new study details just how hard it can be to live with hyperhidrosis and how the condition can negatively impact nearly every aspect of a person’s life. From damaging emotions to not being able to go to the movies – if you’re feeling trapped by sweat, you’re not alone.
With a reach that impacts 99% of the world’s business, and 237,734 employees around the globe, AT&T is an international powerhouse – a powerhouse with a potentially large hyperhidrosis (Hh) population. According to research Hh affects 4.8% of the population, which means that AT&T could have 11,500 employees worldwide dealing with excessive sweating. Helping these employees to perform optimally and to feel valued is part of AT&T’s health and diversity initiatives. Partnering with the International Hyperhidrosis Society (IHhS), AT&T recently added Hh as one of the relatively common medical conditions it recognizes as a disability that can benefit from accommodations at work for employees’ greater comfort, creativity, and productivity.
The American Academy of Dermatology, arguably the world’s most influential dermatology organization, has awarded our co-founder, Dr. David Pariser, with its most prestigious honor — the Gold Medal — and we are not surprised a bit! Discover how Dr. Pariser has been championing hyperhidrosis and dermatologic care for 40 years and how fortunate we are to have his leadership.
